SavedAdd your journal

Journals / Molecular Imaging and Radionuclide Therapy / 2011 / Cilt: 20 - Sayı: 1

Mantle hücreli lenfomada F18-FDG PET/BT ile saptanan göz tutulumu

Ocular involvement in mantle cell lymphoma detected by F 18 FDG PET/CT

ELGİN ÖZKAN
Seda LAÇİN
ÇİĞDEM SOYDAL
MİNE ARAZ
N. Özlem KÜÇÜK
Pages
36–37
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Authors report MCL with ocular involvement that was detected on PET/CT scan. (MIRT 2011; 20: 36-7)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Mantle Cell Lymphoma (MCL) is an uncommon but aggressive form of non-Hodgkin’s lymphoma.
📊
Key Findings & Data:The extranodal involvement is not unusual especially in bone marrow, spleen, gastrointestinal tract and Waldeyer’s ring.
💡
Conclusion & Impact:Authors report MCL with ocular involvement that was detected on PET/CT scan. (MIRT 2011; 20: 36-7)
🔬Design:Research Article
📍Scope:2011 Verileri
⚙️Variables:Domain Parameters

Abstract

Mantle Cell Lymphoma (MCL) is an uncommon but aggressive form of non-Hodgkin’s lymphoma. The extranodal involvement is not unusual especially in bone marrow, spleen, gastrointestinal tract and Waldeyer’s ring. Ocular involvement is very exceptional and the most commonly affected site is the orbit (90%), followed by the lacrimal gland (50%) and the eyelids (50%). Today, PET/CT is widely used in non-Hodgkin’s lenfoma especially in staging and evaluation of treatment response. Authors report MCL with ocular involvement that was detected on PET/CT scan. (MIRT 2011; 20: 36-7)

Özet

Mantle Hücreli Lenfoma (MHL), Hodgkin dışı lenfomanın nadir ancak agresif bir formudur Ekstranodal tutulum nadir değildir ve özellikle kemik iliğinde, dalakta, gastrointestinal sistemde ve Waldeyer halkasında izlenir. Göz tutulumu ise oldukça nadir olup, izlendiğinde en sık etkilenen bölgeler sırasıyla orbita (%90), lakrimal bez (%50) ve göz kapaklarıdır (%50). Günümüzde PET/BT, Hodgkin dışı lenfomada özellikle evreleme ve tedaviye yanıtı değerlendirmede yaygın olarak kullanılmaktadır. Biz bu olguda göz kapağı tutulumu ile seyreden MCL olgusunda PET/BT bulgularını sunduk. (MIRT 2011; 20: 36-7)

🔖

Cite This Article

ÖZKAN, E., LAÇİN, S., SOYDAL, Ç., ARAZ, M., KÜÇÜK, N. Ö. (2011). Mantle hücreli lenfomada F18-FDG PET/BT ile saptanan göz tutulumu. Molecular Imaging and Radionuclide Therapy, Cilt: 20 - Sayı: 1, 36–37. https://ajindex.com/articles/295200

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (6)

  1. Valenzuela AA, Allen C, Grimes D, Wong D, Sullivan TJ. Positron Emission Tomography in the Detection and Staging of Ocular Adnexal Lymphoproliferative Disease. Ophthalmology 2006;113:2331-2337
  2. Argatoff LH, Connors JM, Klasa RJ, Horsman DE, Gascoyne RD. Mantle cell lymphoma: a clinicopathologic study of 80 cases. Blood 1997;15:2067-2078
  3. Bosch F, López-Guillermo A, Campo E, Ribera JM, Conde E, Piris MA, Vallespí T, Woessner S, Montserrat E. Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors. Cancer 1998;1:567-575
  4. Boullanger N, Renou P, Dugay J, Boyer J, de Yberlucea LR, Combe M, Coulon MA. Palpable mantle cell lymphoma in the breast. Presse Med 2001;30:163-165
  5. Rasmussen P, Sjö LD, Prause JU, Ralfkiaer E, Heegaard S. Mantle cell Lymphoma in the orbital and adnexal region. Br J Ophthalmol 2009;93:1047-1051
  6. Looi A, Gascoyne RD, Chhanabhai M, Connors JM, Rootman J, White VA. Mantle cell Lymphoma in the ocular adnexal region. Ophthalmology 2005;112:114-119.